Company: WBD
Filing Date: 2025-04-11
Form Type: 8-K
Source: 0001437107-25-000076
Chunk: 0

Company: Warner Bros. Discovery, Inc.
Filing Date: 2025-04-11
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On April 8, 2025, Dr. John Malone notified the Board of Directors (the “ Board”) of Warner Bros. Discovery, Inc. (the “ Company”) of his decision to not stand for re-election following the expiration of his current term, which will expire at the Company's 2025 Annual Meeting of Stockholders. Dr. Malone is chair of the Company's Nominating and Corporate Governance Committee. His decision not to stand for re-election was not the result of any disagreement with the Company on any matter relating to the Company's operation, policies or practices.

On April 9, 2025, in recognition of Dr. Malone’s service to the Company and his continued interest in contributing to and supporting the Company with his counsel, the Board designated Dr. Malone as Chair Emeritus of the Board, effective as of the Company’s 2025 Annual Meeting of Stockholders. As Chair Emeritus, Dr. Malone will continue to regularly attend Board meetings in an advisory capacity, but will not vote on Board matters.

The Company had previously filed a Form 8-K on March 31, 2025 announcing (i) that the Board had adopted a resolution to increase the size of the Board to fourteen directors, effective immediately following the Company’s 2025 Annual Meeting of Stockholders, as permitted under the Company’s Second Restated Certificate of Incorporation and the Company’s Amended and Restated Bylaws and (ii) that following the future increase in the size of the Board and in accordance with the procedures set forth in the Company's Second Restated Certificate of Incorporation, on March 31, 2025, the Board had appointed Anton Levy to the Board effective immediately following the 2025 Annual Meeting of Stockholders.

On April 9, 2025, in light of Dr. Malone’s decision not to stand for re-election, the Board adopted a resolution to nominate Mr. Levy for election at the Company's 2025 Annual Meeting of Stockholders with a term that expires at the 2026 Annual Meeting of Stockholders and maintain the size of the Board at thirteen directors following the Company's 2025 Annual Meeting of Stockholders.

Item 7.01. Regulation FD Disclosure